Grace & White Inc. NY Purchases 1,871 Shares of SWK Holdings Co. (NASDAQ:SWKH)

Grace & White Inc. NY lifted its position in shares of SWK Holdings Co. (NASDAQ:SWKH) by 11.1% in the fourth quarter, HoldingsChannel.com reports. The firm owned 18,721 shares of the company’s stock after purchasing an additional 1,871 shares during the period. Grace & White Inc. NY’s holdings in SWK were worth $297,000 at the end of the most recent quarter.

Several other large investors also recently modified their holdings of SWKH. Victory Capital Management Inc. bought a new position in SWK during the 3rd quarter valued at approximately $589,000. SkyView Investment Advisors LLC lifted its stake in SWK by 2.1% in the third quarter. SkyView Investment Advisors LLC now owns 31,815 shares of the company’s stock worth $550,000 after acquiring an additional 650 shares during the period. JPMorgan Chase & Co. boosted its holdings in SWK by 224.4% in the third quarter. JPMorgan Chase & Co. now owns 6,108 shares of the company’s stock valued at $106,000 after acquiring an additional 4,225 shares in the last quarter. Finally, Barclays PLC increased its position in SWK by 185.0% during the 3rd quarter. Barclays PLC now owns 4,461 shares of the company’s stock valued at $77,000 after purchasing an additional 2,896 shares during the period. 99.27% of the stock is owned by institutional investors.

SWK Trading Down 1.0 %

NASDAQ:SWKH opened at $16.50 on Thursday. The company has a 50-day moving average price of $16.31 and a 200-day moving average price of $16.62. The stock has a market cap of $201.80 million, a price-to-earnings ratio of 17.74 and a beta of 0.37. The company has a current ratio of 5.06, a quick ratio of 5.06 and a debt-to-equity ratio of 0.11. SWK Holdings Co. has a 12 month low of $15.14 and a 12 month high of $18.49.

SWK Company Profile

SWK Holdings Corporation, offers specialty finance and asset management services in the United States. It operates in two segments, Finance Receivables and Pharmaceutical Development. The Finance Receivables segment provides customized financing solutions to a range of life science companies, including companies in the biotechnology, medical device, medical diagnostics and related tools, animal health, and pharmaceutical industries, as well as institutions and inventors.